Questions raised over genetic sequence in Moderna patent
chinadaily.com.cn |
Updated: 2022-03-25 08:53
Share
Share - WeChat
An international team of scientists recently found that a small piece of genetic sequence in the coronavirus is identical to a partial genetic sequence patented by Moderna, the American pharmaceutical company, prior to the COVID-19 pandemic, sparking debate.
Most Viewed in 24 Hours
